胸腺癌-话题@MedSci - 梅斯（MedSci）

#胸腺癌#

10篇内容 | 1029人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2078106, encodeId=293520e8106d4, content=<a href='/topic/show?id=612e8419336' target=_blank style='color:#2F92EE;'>#胸腺癌#</a>, objectTitle=European Radiology：这些征象提示了什么？胸腺瘤、胸腺癌和淋巴瘤的影像学鉴别, objectType=article, longId=294407, objectId=4f9d29440e72, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f9d29440e72, replyNumber=0, likeNumber=71, createdTime=2022-06-28, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f9d29440e72, moduleTitle=European Radiology：这些征象提示了什么？胸腺瘤、胸腺癌和淋巴瘤的影像学鉴别, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4f9d29440e72)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078105, encodeId=6bb820e81051f, content=<a href='/topic/show?id=612e8419336' target=_blank style='color:#2F92EE;'>#胸腺癌#</a>, objectTitle=Front Oncol：顺铂联合伊立替康一线治疗转移性或不能切除的胸腺癌疗效显著耐受性好, objectType=article, longId=294107, objectId=35b729410e5b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35b729410e5b, replyNumber=0, likeNumber=93, createdTime=2022-11-28, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35b729410e5b, moduleTitle=Front Oncol：顺铂联合伊立替康一线治疗转移性或不能切除的胸腺癌疗效显著耐受性好, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=35b729410e5b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078103, encodeId=72d220e81035f, content=<a href='/topic/show?id=612e8419336' target=_blank style='color:#2F92EE;'>#胸腺癌#</a>, objectTitle=NCCN临床实践指南：胸腺瘤和胸腺癌（2019.V1）, objectType=article, longId=160570, objectId=46021605e0a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46021605e0a8, replyNumber=0, likeNumber=78, createdTime=2019-10-13, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46021605e0a8, moduleTitle=NCCN临床实践指南：胸腺瘤和胸腺癌（2019.V1）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=46021605e0a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078104, encodeId=fb8020e810464, content=<a href='/topic/show?id=612e8419336' target=_blank style='color:#2F92EE;'>#胸腺癌#</a>, objectTitle=NCCN临床实践指南：胸腺瘤和胸腺癌（2019.V2）, objectType=article, longId=164266, objectId=79f31642663f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79f31642663f, replyNumber=0, likeNumber=65, createdTime=2019-11-20, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79f31642663f, moduleTitle=NCCN临床实践指南：胸腺瘤和胸腺癌（2019.V2）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=79f31642663f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078102, encodeId=fde820e81027f, content=<a href='/topic/show?id=612e8419336' target=_blank style='color:#2F92EE;'>#胸腺癌#</a>, objectTitle=NCCN临床实践指南：胸腺瘤和胸腺癌（2018.V2）, objectType=article, longId=130800, objectId=224813080011, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=224813080011, replyNumber=0, likeNumber=75, createdTime=2018-09-14, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=224813080011, moduleTitle=NCCN临床实践指南：胸腺瘤和胸腺癌（2018.V2）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=224813080011)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078100, encodeId=738f20e810036, content=<a href='/topic/show?id=612e8419336' target=_blank style='color:#2F92EE;'>#胸腺癌#</a>, objectTitle=JCO：依维莫司治疗铂基化疗后胸腺瘤或胸腺癌患者, objectType=article, longId=123564, objectId=9ce9123564c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ce9123564c7, replyNumber=0, likeNumber=95, createdTime=2018-05-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ce9123564c7, moduleTitle=JCO：依维莫司治疗铂基化疗后胸腺瘤或胸腺癌患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9ce9123564c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078101, encodeId=17dd20e81012e, content=<a href='/topic/show?id=612e8419336' target=_blank style='color:#2F92EE;'>#胸腺癌#</a>, objectTitle=Lancet oncol：派姆单抗用于治疗晚期胸腺癌的效果和安全性, objectType=article, longId=128001, objectId=1589128001e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1589128001e0, replyNumber=0, likeNumber=101, createdTime=2018-02-01, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1589128001e0, moduleTitle=Lancet oncol：派姆单抗用于治疗晚期胸腺癌的效果和安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1589128001e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078099, encodeId=755620e8099a2, content=<a href='/topic/show?id=612e8419336' target=_blank style='color:#2F92EE;'>#胸腺癌#</a>, objectTitle=Lancet Oncol：舒尼替尼治疗化疗难治性胸腺瘤和胸腺癌---项开放的II期临床研究, objectType=article, longId=46140, objectId=3e594614037, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e594614037, replyNumber=0, likeNumber=89, createdTime=2015-11-23, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e594614037, moduleTitle=Lancet Oncol：舒尼替尼治疗化疗难治性胸腺瘤和胸腺癌---项开放的II期临床研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3e594614037)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078098, encodeId=704c20e809808, content=<a href='/topic/show?id=612e8419336' target=_blank style='color:#2F92EE;'>#胸腺癌#</a>, objectTitle=The Lancet Oncology：前哨淋巴阳性的胸腺癌患者腋下放射治疗或手术治疗, objectType=article, longId=41416, objectId=1653414166c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1653414166c, replyNumber=0, likeNumber=77, createdTime=2015-02-08, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1653414166c, moduleTitle=The Lancet Oncology：前哨淋巴阳性的胸腺癌患者腋下放射治疗或手术治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1653414166c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078097, encodeId=d2ec20e80970e, content=<a href='/topic/show?id=612e8419336' target=_blank style='color:#2F92EE;'>#胸腺癌#</a>, objectTitle=Ann Thorac Surg：胸腺癌术中淋巴结清扫可使患者获益, objectType=article, longId=23675, objectId=0d14236e5f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d14236e5f2, replyNumber=0, likeNumber=76, createdTime=2014-07-24, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d14236e5f2, moduleTitle=Ann Thorac Surg：胸腺癌术中淋巴结清扫可使患者获益, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0d14236e5f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

胸腺癌

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#胸腺癌#

European Radiology：这些征象提示了什么？胸腺瘤、胸腺癌和淋巴瘤的影像学鉴别

2022-06-28

仁者大医 (审核中...)

前往app查看评论内容

#胸腺癌#

Front Oncol：顺铂联合伊立替康一线治疗转移性或不能切除的胸腺癌疗效显著耐受性好

2022-11-28

仁者大医 (审核中...)

前往app查看评论内容

#胸腺癌#

NCCN临床实践指南：胸腺瘤和胸腺癌（2019.V1）

2019-10-13

智慧医人 (审核中...)

前往app查看评论内容

#胸腺癌#

NCCN临床实践指南：胸腺瘤和胸腺癌（2019.V2）

2019-11-20

仁者大医 (审核中...)

前往app查看评论内容

#胸腺癌#

NCCN临床实践指南：胸腺瘤和胸腺癌（2018.V2）

2018-09-14

仁者大医 (审核中...)

前往app查看评论内容

#胸腺癌#

JCO：依维莫司治疗铂基化疗后胸腺瘤或胸腺癌患者

2018-05-07

仁者大医 (审核中...)

前往app查看评论内容

#胸腺癌#

Lancet oncol：派姆单抗用于治疗晚期胸腺癌的效果和安全性

2018-02-01

jianjun66 (审核中...)

前往app查看评论内容

#胸腺癌#

Lancet Oncol：舒尼替尼治疗化疗难治性胸腺瘤和胸腺癌---项开放的II期临床研究

2015-11-23

jianjun66 (审核中...)

前往app查看评论内容

#胸腺癌#

The Lancet Oncology：前哨淋巴阳性的胸腺癌患者腋下放射治疗或手术治疗

2015-02-08

jianjun66 (审核中...)

前往app查看评论内容

#胸腺癌#

Ann Thorac Surg：胸腺癌术中淋巴结清扫可使患者获益

2014-07-24

科室
- - 订阅+
  - 更多科室
工具
服务